Copyright
©2012 Baishideng.
World J Stem Cells. Jul 26, 2012; 4(7): 62-70
Published online Jul 26, 2012. doi: 10.4252/wjsc.v4.i7.62
Published online Jul 26, 2012. doi: 10.4252/wjsc.v4.i7.62
miRNA | Functions in stem cells | Mechanism(s) | Ref. |
Pluripotent miRNAs | |||
miR-290 cluster, miR-370, miR-302 | Promotes self-renewal | Regulate embryonic stem cell cycle | [32] |
miR-141, miR-200, miR-429 | Maintenance of self-renewal in the absence of leukemia inhibitory factor | Regulated by cMyc proteins | [66] |
miR-9 | Proliferation and promote NSC migration | Target Stmn1, which increases microtubule instability | [67] |
Neurite outgrowth | Inhibit Cdc42 expression and altering the localization of Rac1 | ||
miR-184 | NSC proliferation | Represses the expression of Numb-like 1 | [68] |
miR-137 | Promotes NSC proliferation but inhibits neuronal maturation, dendritic morphogenesis, and spine development | Target Mind bomb 1, an ubiquitin ligase | [69] |
Pro-differentiation miRNAs | |||
miR-134, miR-145, miR-296, miR-470 | Initiate differentiation | Suppress pluripotent markers including Nanog, Oct4, Sox, Klf4 | [33] |
Let-7 | Stabilize differentiation | Target transcripts that are regulated by the pluripotency transcription factors Oct4, Sox2, Nanog and Tcf3 | [34] |
Promote somatic cell cycle by targeting both directly and indirectly the multiple activators of the G1-S transition including cdc25a, cdk6, cyclinD1 and cyclinD2 | [35-37] | ||
miR-124 | NSC differentiation | Suppress Sox9 expression in adult NSCs and exhibit mutual inhibition mechanism of Ephrin-B1 | [70] |
miRNA | Tumor type | Mechanism(s) | Ref. |
miRNA as oncomiR | |||
miR-17-92 polycistron | Upregulated in lung, breast, stomach, prostate, colon and pancreatic cancers | Regulate c-Myc expression | [46,47] |
miR-21, miR-205 | Head and neck cancer | Target transcripts of tumor suppressive genes including kinesin family member 1B isoform α, hypermethylated in cancer 2, and pleomorphic adenoma gene 1 | [71] |
miR-372, miR-373 | Testicular germ cells | Neutralize p53-mediated CDK inhibition, possibly through direct inhibition of the expression of the tumor-suppressor LATS2 | [72] |
miR-21 | Breast cancer | Target tumor suppressor tropomyosin 1 | [73] |
miR-126 | Gastric carcinoma | Targets SOX2, and PLAC1 | [48] |
Let-7 | Hepatocellular carcinoma | Targets SOCS1, caspase-3 | [56] |
miR-181 | Hepatocellular carcinoma | Targets RASSF1A, TIMP3 as well as nemo-like kinase | [56] |
miR-495 | Breast cancer | Modulated by transcription factor E12/E47, suppresses E-cadherin expression to promote cell invasion and inhibits regulated in development and DNA damage responses 1 expression to enhance cell proliferation in hypoxia through post-transcriptional mechanism | [74] |
miRNAs as tumor suppressors | |||
Let-7 | Colon adenocarcinomas | Target Lin-28b which promotes cell migration, invasion and transforms immortalized colonic epithelial cells | [50] |
miR-15 miR-16 cluster | Chronic lymphocytic leukemia | Targets the apoptotic inhibitor Bcl-2 | [47] |
miR-29 | Cholangiocarcinoma | Regulate the anti-apoptotic protein Mcl-1 | [75] |
miR200c | Head and neck squamous cell carcinoma | Negatively modulates the expression of BMI1 and ZEB1 | [62] |
miR-125b | Glioma | Decreases the cell cycle regulated proteins CDK6 and CDC25A | [76] |
- Citation: Garg M. MicroRNAs, stem cells and cancer stem cells. World J Stem Cells 2012; 4(7): 62-70
- URL: https://www.wjgnet.com/1948-0210/full/v4/i7/62.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v4.i7.62